RBC Capital Cuts Myriad (MYGN) Price Target to 24

December 30, 2013 11:15 AM EST Send to a Friend
RBC Capital maintains Myriad Genetics (Nasdaq: mygn) at Sector Perform, but eases its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login